Research study Program year 2025 Source: CMS Open Payments

Multicenter, randomised, double-blind, placebo-controlled, 48 week, Phase III trial to evaluate the efficacy and safety of survodutide administered subcutaneously in participants with overweight or obesity and presumed or confirmed non-alcoholic steatohepatitis (NASH)

Research payments

$15,025,661

7,535 payments

Through program year 2025, $15,025,661 in research payments was reported against Multicenter, randomised, double-blind, placebo-controlled, 48 week, Phase III trial to evaluate the efficacy and safety of survodutide administered subcutaneously in participants with overweight or obesity and presumed or confirmed non-alcoholic steatohepatitis (NASH), across 7,535 payments, paid by Boehringer Ingelheim International GmbH.

Paid by
Boehringer Ingelheim International GmbH
ClinicalTrials.gov
No trial number was reported for this study

By program year

1 row
Year Kind Amount Payments
2025 Research $15,025,661 7,535

Breakdown

Who paid Research payments · program year 2025
  1. Boehringer Ingelheim International GmbH $15,025,661 7,535 payments
Who received the money Research payments · program year 2025
  1. Verus Clinical Research Corporation Organisation paid for research $2,784,907 1,095 payments
  2. Covenant Research Organisation paid for research $2,512,185 1,234 payments
  3. Covenant Metabolic Specialists-Fort Myers Organisation paid for research $2,268,470 1,072 payments
  4. Louisiana Research Center Organisation paid for research $1,492,832 467 payments
  5. Health Awareness Organisation paid for research $925,150 340 payments
  6. Dr Bruce A Segal MD PA Organisation paid for research $846,704 365 payments
  7. Excel Medical Clinical Trials LLC Organisation paid for research $411,064 217 payments
  8. University Of Iowa Hosp & Clinics Teaching hospital · IA $388,780 187 payments
  9. Kansas Medical Clinic PA Organisation paid for research $368,166 231 payments
  10. Velocity Clinical Research-Panorama City Organisation paid for research $351,959 222 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record